{
    "prompt": "Please provide each treatment as a json format with the following JSON schema.\n    {\n        \"Treatment 1\": {\n            \"Disease Name\": ,\n            \"Disease Phase or Condition\": ,\n            \"Drug Name\": ,\n            \"Prior Treatment or Resistance Status\": ,\n            \"Genomic Features\":\n            \"Link to FDA-approved Label\": \n            }\n    }\n    Query: \n    The following is a summarized molecular profile from MSK-IMPACT.\n    Based on this profile, answer with the appropriate treatments for this patient in the format above.\n    Patient ID: P-0024768\nAge: 49\nGender: Male\nSample ID: P-0024768-T01-IM6\nGene Panel: IMPACT468\nCancer Type: Colon Adenocarcinoma\nSample Type: Primary\nTumor Purity: 20.0%\n=============\nDNA Variants:\nAPC c.4393_4394del (p.S1465Wfs*3) - in 13.00% of 474 reads\nAPC c.2932del (p.Q978Kfs*2) - in 12.00% of 395 reads\nATR c.1007G>T (p.R336L) - in 8.00% of 530 reads\nATRX c.6253C>T (p.R2085C) - in 21.00% of 262 reads\nBRAF c.1799T>A (p.V600E) - in 11.00% of 463 reads\nEP300 c.6970dup (p.H2324Pfs*55) - in 13.00% of 657 reads\nIKZF1 c.247C>T (p.R83*) - in 12.00% of 418 reads\nPIK3CA c.1633G>A (p.E545K) - in 12.00% of 393 reads\nRPTOR c.157G>T (p.D53Y) - in 10.00% of 420 reads\nTP53 c.524G>A (p.R175H) - in 17.00% of 542 reads\nZFHX3 c.4508_4513del (p.Q1503_S1504del) - in 12.00% of 572 reads\nCNA Data:\nNo CNA data found.\nStructural Variants:\nNo structural variant data found.\n    ",
    "response": "{\n  \"Treatment 1\": {\n    \"Disease Name\": \"Metastatic Castration-Resistant Prostate Cancer\",\n    \"Disease Phase or Condition\": \"Metastatic castration-resistant prostate cancer (mCRPC)\",\n    \"Drug Name\": \"Olaparib\",\n    \"Prior Treatment or Resistance Status\": \"Progressed following prior treatment with enzalutamide or abiraterone\",\n    \"Genomic Features\": [\n      \"BRIP1 (somatic variant)\",\n      \"CHEK1 (somatic variant)\",\n      \"ATM (somatic variant)\",\n      \"RAD51C (somatic variant)\",\n      \"BARD1 (somatic variant)\",\n      \"RAD54L (somatic variant)\"\n    ],\n    \"Link to FDA-approved Label\": \"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208558s025lbl.pdf\"\n  }\n}"
}